top of page

AstraZeneca & Kunsen: 2024 Hematology Challenge Finalist

  • Writer: Altum Sequencing
    Altum Sequencing
  • Jun 4
  • 1 min read

Selected as a finalist in the "Hematology Challenge" organized by AstraZeneca and Kunsen, an initiative dedicated to finding innovative solutions for clinical management in hematology. The company was recognized for its advanced software and genomic approach, aimed at optimizing diagnosis and monitoring for patients with blood cancers.



Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page